Society for Immunotherapy of Cancer shared on LinkedIn:
“Implement the latest FDA-approved cancer immunotherapies into practice and improve patient outcomes with sitcancer’s Clinical Practice Guidelines. Guidelines feature recommended therapies, toxicity management and more! “.
Read further.
Source: Society for Immunotherapy of Cancer/LinkedIn